1998
DOI: 10.2745/dds.13.101
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy with hybrid liposomes for cancer: An experimental study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…In addition, Nakano et al (19) also found growth inhibition when hybrid liposome was added to human hepatoma cells in vitro. Furthermore, the hybrid liposomes have been found to have a highly inhibitory effect on mice model of carcinoma in vivo (20). Matsumoto et al (7) also reported that hybrid liposomes of lipid and micellar molecules inhibit the growth of HL-60 cells.…”
Section: Discussionmentioning
confidence: 96%
“…In addition, Nakano et al (19) also found growth inhibition when hybrid liposome was added to human hepatoma cells in vitro. Furthermore, the hybrid liposomes have been found to have a highly inhibitory effect on mice model of carcinoma in vivo (20). Matsumoto et al (7) also reported that hybrid liposomes of lipid and micellar molecules inhibit the growth of HL-60 cells.…”
Section: Discussionmentioning
confidence: 96%
“…3 Hybrid liposomes are highly expected to be very useful as a new material in the medical field because of their bioadaptability, easiness of preparation than the ordinary methods, and no contamination with any organic solvents. It has been reported that hybrid liposomes demonstrated remarkable inhibitory effects on the growth of lymphoma, 4À6 leukemia, 7 melanoma, 8 and lung adenocarcinoma 9 cells.…”
mentioning
confidence: 99%
“…11 Significantly prolonged survival was obtained using mice model of carcinoma in vivo. 8 It is well known that hydrophilic peptides like insulin are not sufficiently encapsulated to the liposomes. In order to improve the encapsulation of insulin into liposomes, we prepared the acylated insulins modified with hydrophobic groups, that is, long chain caproyl (Cap) and aromatic benzoyl (Bz) groups.…”
mentioning
confidence: 99%